share_log

新銳醫藥:截至2024年5月31日之股份發行人的證券變動月報表

NEW RAY MEDIC: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2024

Hong Kong Stock Exchange ·  Jun 3 16:59
Summary by Futu AI
新銳醫藥國際控股有限公司(新銳醫藥)於2024年6月3日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年5月31日的公司股份變動情況。報告顯示,新銳醫藥的法定/註冊股本及已發行股份在報告期內均無變動,維持在3,000,000,000股,每股面值0.05港元,總股本為150,000,000港元。此外,根據2013年10月25日採納的股份期權計劃,本月底結存的股份期權數目為143,200,000,並無本月內變動。公司確認所有證券發行均已獲得董事會正式授權批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
新銳醫藥國際控股有限公司(新銳醫藥)於2024年6月3日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年5月31日的公司股份變動情況。報告顯示,新銳醫藥的法定/註冊股本及已發行股份在報告期內均無變動,維持在3,000,000,000股,每股面值0.05港元,總股本為150,000,000港元。此外,根據2013年10月25日採納的股份期權計劃,本月底結存的股份期權數目為143,200,000,並無本月內變動。公司確認所有證券發行均已獲得董事會正式授權批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
On June 3, 2024, New Ray Medic International Holdings Limited (New Ray Medic) submitted the latest monthly securities change report to Hong Kong Exchanges and Clearing Limited, reporting on the company's share changes as of May 31, 2024. The report shows that New Ray Medic's authorized/registered share capital and issued shares remained unchanged during the reporting period, remaining at 3,000,000,000 shares with a par value of HKD 0.05 per share, and a total share capital of HKD 150,000,000. In addition, according to the stock option plan adopted on October 25, 2013, the number of stock options outstanding at the end of this month is 143,200,000, with no changes during this month. The company confirms that all securities issuances have been formally authorized and approved by the Board of Directors, and comply with the relevant requirements of the Listing Rules of the Hong Kong Stock Exchange.
On June 3, 2024, New Ray Medic International Holdings Limited (New Ray Medic) submitted the latest monthly securities change report to Hong Kong Exchanges and Clearing Limited, reporting on the company's share changes as of May 31, 2024. The report shows that New Ray Medic's authorized/registered share capital and issued shares remained unchanged during the reporting period, remaining at 3,000,000,000 shares with a par value of HKD 0.05 per share, and a total share capital of HKD 150,000,000. In addition, according to the stock option plan adopted on October 25, 2013, the number of stock options outstanding at the end of this month is 143,200,000, with no changes during this month. The company confirms that all securities issuances have been formally authorized and approved by the Board of Directors, and comply with the relevant requirements of the Listing Rules of the Hong Kong Stock Exchange.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.